We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
-1.41%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$587M
AUM Growth
-$12.4M
Cap. Flow
+$16.1M
Cap. Flow %
2.74%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
AST
Asterias Biotherapeutics Inc. Series A
AST
+$9.59M
2
STAA icon
STAAR Surgical
STAA
+$6.49M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 63.5%
2 Consumer Staples 36.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
1
Monster Beverage
MNST
$87.5B
$214M 36.5%
19,189,632
– –
MNK
2
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$191M 32.47%
1,619,968
– –
STAA icon
3
STAAR Surgical
STAA
$1.14B
$78.4M 13.35%
8,117,582
+700,000
+9% +$6.49M
LCTX icon
4
Lineage Cell Therapeutics
LCTX
$263M
$64.7M 11.02%
22,095,035
– –
CYNO
5
DELISTED
Cynosure, Inc. Class A
CYNO
$31.5M 5.37%
817,029
– –
AST
6
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$7.55M 1.29%
1,641,025
+1,000,000
+156% +$9.59M

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2015 Portfolio in Review

As of Q2 2015, Broadwood Capital held 6 positions worth $587M, down 2.1% from $600M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2015: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 64% of assets, up from 63% a quarter earlier, followed by Consumer Staples.

  • Broadwood Capital added most to Asterias Biotherapeutics Inc. Series A in Q2 2015, an estimated $9.59M increase.
  • Broadwood Capital's ten largest holdings make up 100% of its $587M portfolio in Q2 2015.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2015.
  • Broadwood Capital's portfolio value fell 2.1% quarter-over-quarter to $587M.

Based on Broadwood Capital's 13F filing for Q2 2015, filed 14 Aug 2015.